Pharmaceuticals & Biotech

Value-based care and innovation-driven pharma

By Tai Chung

Nov. 8, 2021 | Webinar | 54-minute watch

Value-based care and innovation-driven pharma

Pharma can leverage value-based care/contracts (VBCs) to differentiate and demonstrate the effectiveness of their beyond-the-pill initiatives versus their competitors, which can assist payers in making formulary and other reimbursement decisions. Payers can use VBCs to gain experience with a beyond-the-pill solution or program, reducing uncertainty regarding clinical value, performance and financial impact.


This webinar highlights the opportunities and risks of VBC for innovation-driven pharmaceutical organizations that are either wading or diving head first into the digital health space.

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.